Lipoprotein metabolism and CKD: overview (Q38139864)

29 August 2017

Lipoprotein metabolism and CKD: overview (English)

1 reference

29 August 2017

1 reference

Philip Barter

1

1 reference

29 August 2017

20 September 2013

1 reference

Clinical and experimental nephrology

29 August 2017

1 reference

29 August 2017

18

1 reference

29 August 2017

243-246

1 reference

29 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s10157-013-0866-9

29 August 2017

0 references

cites work

Dyslipidemia of kidney disease

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0866-9

Lipoprotein metabolism and lipid management in chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0866-9

Lipid and lipoprotein metabolism in chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0866-9

Lipoprotein metabolism and renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0866-9

Hepatic HDL receptor, SR-B1 and Apo A-I expression in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0866-9

Antiinflammatory properties of HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0866-9

Effects of high-density lipoproteins on pancreatic beta-cell insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0866-9

Down-regulation of tissue lipoprotein lipase expression in experimental chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0866-9

Lipoprotein lipase deficiency in chronic kidney disease is accompanied by down-regulation of endothelial GPIHBP1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0866-9

Selective Deficiency of Hepatic Triglyceride Lipase in Uremic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0866-9

Down-regulation of hepatic lecithin:cholesterol acyltransferase gene expression in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0866-9

Hepatic lipase mutation may reduce vascular disease prevalence in hemodialysis patients with high CETP levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0866-9

Lecithin-cholesterol acyltransferase (LCAT) activity in chronic uremia

21 January 2018

1 reference

12 December 2020

Alterations of paraoxonase and platelet-activating factor acetylhydrolase activities in patients on peritoneal dialysis.

1 reference

12 December 2020

Serum Lp(a) levels in patients with moderate renal failure

1 reference

12 December 2020

Increased lipoprotein(a) concentrations in chronic renal failure

1 reference

12 December 2020

Atherogenic lipoprotein phenotype in end-stage renal failure: origin and extent of small dense low-density lipoprotein formation

1 reference

12 December 2020

The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase

1 reference

12 December 2020

Low-density lipoprotein subfraction profiles in chronic renal failure

1 reference

12 December 2020

Serum paraoxonase activity in uremic predialysis and hemodialysis patients.

1 reference

12 December 2020

10.1007/S10157-013-0866-9

Identifiers

DOI

1 reference

29 August 2017

1 reference

PubMed ID

24052157